Scope Biosciences B.V.

Scope Biosciences develops ScopeDx: the next generation of molecular diagnostics. This platform technology uses proprietary Type III CRISPR-Cas to detect nucleic acid sequences. Transforming our ability to detect genetic material with ease, speed and incredible accuracy.